PowerPoint Presentation - I. Introduction to class

Download Report

Transcript PowerPoint Presentation - I. Introduction to class

INNATE IMMUNITY

 

BARRIERS CELLS: MACROPHAGES, PLASMA CELLS, NK CELLS LYMPHOCYTES,

CYTOKINES /CHEMOKINES

PLASMA PROTEINS: Coagulation Factors Complement,

Toll-Like Receptors, TLR’s

Innate immunity

 A hallmark of the innate immune system is that it has no memory of a previous encounter with a foreign organism. The system is good at dealing with extracellular bacteria, fungi and intracellular viruses .

ADAPTIVE IMMUNITY

CELLULAR,

i.e., direct cellular reactions to antigens

HUMORAL,

antibodies i.e.,

Adaptive (acquired) immunity

Refers to antigen-specific defense mechanisms that take several days to become protective and are

designed to remove a specific antigen. This is the immunity one develops throughout life. There are two major branches of the adaptive immune responses: 1. Humoral immunity : involves the production of antibody molecules in response to an antigen and is mediated by B-lymphocytes.

2. cell-mediated immunity : involves the production of cytotoxic T-lymphocytes, activated macrophages, activated NK cells, and cytokines in response to an antigen and is mediated by T-lymphocytes.

CELLS

of the IMMUNE SYSTEM

     

LYMPHOCYTES,

T

LYMPHOCYTES,

B PLASMA CELLS (MODIFIED B CELLS) MACROPHAGES

, aka “HISTIOCYTES”, (APCs, i.e., Antigen Presenting Cells) “

DENDRITIC

” CELLS (APCs, i.e., Antigen Presenting Cells)

NK

(NATURAL KILLER)

CELLS

NK CELLS

MHC M

ajor

H

istocompatibility

C

omplex

A genetic “LOCUS” on Chromosome 6, which codes for cell surface compatibility

Also called HLA (Human Leukocyte Antigens) in humans and H-2 in mice

It’s major job is to make sure all self cell antigens are recognized and “tolerated”, because the general rule of the immune system is that all UN-recognized antigens will NOT be tolerated

GENERAL SCHEME of CELLULAR EVENTS

 

APCs (Macrophages, Dendritic Cells)

T-Cells

(Control Everything)

CD4

“REGULATORS” (Helper)

  

CD8

“EFFECTORS” B-Cells

NK Cells

Plasma Cells

AB’s

    

CYTOKINES

Cytokines are produced by a broad range of cells, including immune cells like macrophages , B lymphocytes as endothelial cells , fibroblasts , and various stromal cells ; , T lymphocytes and mast cells , as well

MEDIATE INNATE (NATURAL) IMMUNITY, IL-1, TNF, INTERFERONS REGULATE ILs) LYMPHOCYTE GROWTH (many interleukins, ACTIVATE INFLAMMATORY CELLS STIMULATE HEMATOPOESIS, (CSFs, or S timulating F actors ) C olony

CYTOKINES/CHEMOKINES

  

CYTOKINES are PROTEINS produced by MANY cells, but usually LYMPHOCYTES and MACROPHAGES, numerous roles in acute and chronic inflammation, AND immunity

TNF

,

IL-1

, by macrophages

CHEMOKINES are small proteins which are attractants for PMNs

They are important in health and disease, specifically in host responses to infection, immune responses, inflammation , trauma, sepsis , cancer, and reproduction.

MHC MOLECULES

I

(Gene Products)

(All nucleated cells and platelets), cell surface glycoproteins, ANTIGENS 

II

(APC’s, i.e., macs and dendritics, lymphs), cell surface glycoproteins, ANTIGENS 

III

Complement System Proteins

IMMUNE SYSTEM DISORDERS WHAT CAN GO WRONG?

 

HYPERSENSITIVITY REACTIONS, I-IV “AUTO”-IMMUNE DISEASES, aka “COLLAGEN” DISEASES (BAD TERM) Inflammation NOT due to external pathogens, MHC failure.

 

IMMUNE DEFICIENCY SYNDROMES, IDS : PRIMARY (GENETIC)

SECONDARY ( A CQUIRED)

HYPERSENSITIVITY

When the immune systems cause harm to the body, it is referred to as a hypersensitivity

Four Types of Hypersensitivity Reactions:

Type I (Anaphylactic) Reactions

Type II (Cytotoxic) Reactions

Type III (Immune Complex) Reactions

Type IV (Cell-Mediated) Reactions

1.Anaphylactic hypersensitivity

systemic anaphylaxis

- the allergin is usually picked up by the blood and the reactions occur throughout the body. Examples include severe allergy to insect stings, drugs, and antisera.

localized anaphylaxis

- the allergin is usually found localized in the mucous membranes or the skin. Examples include allergy to hair, pollen, dust, dander, feathers, and food.

Disorders

- Atopy ( Atopic syndrome ) - Asthma - Anaphylaxis

 The process of anaphylaxis consists of the following sequential events: 

First exposure:

to an antigen (allergen),such as bee venom, results in production of IgE class of antibodies by plasma cells.

 The surface of mast cells contains specific receptors for IgE.

 IgE molecules are bound to their receptors on the surface of mast cells and basophils.

Second exposure:

• • • • results in binding of the antigen to IgE on the mast cells .

 This then triggers the release of mast cell granules, which are : Histamine secretion. -causes constriction of smooth muscles ( ex bronchioles ), vasodilatation, Increased capillary permeability, increase bronchial mucus Chemotactic factors for eosinophils, proteases.

Leukotrienes -causes bronchial spasms.

Prostaglandins

 

Histamine : Dilates and increases permeability of blood vessels (swelling and redness), increases mucus secretion (runny nose), smooth muscle contraction (bronchi).

Prostaglandins : Contraction of smooth muscle of respiratory system and increased mucus secretion.

Leukotrienes : Bronchial spasms.

Anaphylactic shock : Massive drop in blood pressure. Can be fatal in minutes.

Mast Cells and the Allergic Response

2.

Antibody-dependent cytotoxicity

Mechanism:

Either

IgG or IgM

is made against normal self antigens

as a result of a failure in immune tolerance, or a foreign antigen

resembling some molecule on the

surface of host cells enters the body

and IgG or IgM made against that antigen then cross reacts with the host cell surface.

The binding of these antibodies to the surface of host cells then leads to:

 

Opsonization of the host cell. Activation of the classical complement pathway causing MAC lysis ( membrane attack complex ) of the cells.

ADCC (Antibody-Dependent Cell Mediated Cytotoxicity ) destruction of the host cells.

Complement system

    It consists of series of proteins synthesised by liver as acute phase reactants.

1. Augments host immune defenses 2.Lysis bacteria directly with MAC 3. Participates in cytotoxic immunity and immune complex hypersensitivity reactions.

     The multiple activities of the complement system: Lysis Opsonization Activation of inflammatory response Clearance of immune complexes

      C3a……….Anaphylotoxin

C3b………..opsonin

C5a………..Anaphylotoxin, Adhesion, Chemotactic C5b67…………..Chemotactic complex C5b6789…………………MAC MAC; Membrane attack complex

OPSONIZATION

MAC LYSIS

ADCC

Disorders: -Mismatched blood group

-

Autoimmune hemolytic anemia -Thrombocytopenia -Erythroblastosis fetalis -Goodpasture's syndrome -Membranous nephropathy

3.

Immune complex-mediated

Mechanism:

This is caused when soluble antigen-antibody (IgG or IgM) complexes, which are normally removed by macrophages in the spleen and liver, form in large amounts and overwhelm the body . These small complexes lodge in the capillaries, pass between the endothelial cells of blood vessels - especially those in the skin, joints, and kidneys - and become trapped on the surrounding basement membrane beneath these cells.

• The antigen/antibody complexes then activate the classical complement pathway. This may cause: 

Massive inflammation

, due to complement protein C5a triggering mast cells to release inflammatory mediators;

Influx of neutrophils

, due to complement protein C5a , resulting in neutrophils discharging their lysosomes and causing tissue destruction and further inflammation

MAC lysis

of surrounding tissue cells, due to the membrane attack complex, C5b6789n; 

Aggregation of platelets

, resulting in more inflammation and the formation of microthrombi that block capillaries;

Activation of macrophages

, resulting in production of inflammatory cytokines and extracellular killing causing tissue destruction.

Associated disorders:

serum sickness, a combination type I and

    

type III hypersensitivity.

autoimmune acute glomerulonephritis.

 

rheumatoid arthritis.

systemic lupus erythematosus.

the skin lesions of syphilis and leprosy.

Arthus reaction.

Post streptococcal glomerulonephritis.

Lupus Nephritis.

Extrinsic allergic alveolitis (Hypersensitivity pneumonitis)

Delayed hypersensitivity

cell-mediated rather than antibody mediated.

T8-lymphocytes become sensitized to an antigen and differentiate into cytotoxic T lymphocytes while effector T4 lymphocytes become sensitized to an

antigen and produce cytokines . CTLs, cytokines, eosinophils, and/or macrophages then cause harm rather than benefit.

Summary of Hypersensitivity reactions

Production of antibodies to substances most tolerate, ie allergies.

 Type I (acute)    Most common, starts within seconds and most often ends within 30 minutes .

Anaphylaxis – causes edema, mucus, and congestion Asthma – reaction to inhaled allergen.

 Causes massive release of histamine and spasmatic contraction of the bronchioles.

Anaphylactic shock – systemic response to an injected allergen.  Can cause bronchiolar constriction, circulatory shock, and possible death.

 Type II (antibody-dependant cytotoxic) transfusion reaction.

as in  Type III (immune complex) large antibody-antigen complexes that get trapped under the tunic interna of blood vessels and cause inflammation.

 Type IV (delayed) occur 12 to 72 hours after exposure. Delay commonly associated with travel time to lymph nodes. Cosmetics and poison ivy hapten commonly do this.

Hypersensitivity

Production of antibodies to substances most tolerate, ie allergies.

 Type I (acute)    Most common, starts within seconds and most often ends within 30 minutes .

Anaphylaxis – causes edema, mucus, and congestion Asthma – reaction to inhaled allergen.

 Causes massive release of histamine and spasmatic contraction of the bronchioles.

Anaphylactic shock – systemic response to an injected allergen.  Can cause bronchiolar constriction, circulatory shock, and possible death.

 Type II (antibody-dependant cytotoxic) transfusion reaction.

as in  Type III (immune complex) large antibody-antigen complexes that get trapped under the tunic interna of blood vessels and cause inflammation.

 Type IV (delayed) occur 12 to 72 hours after exposure. Delay commonly associated with travel time to lymph nodes. Cosmetics and poison ivy hapten commonly do this.

T helper cell function

They help the activity of other immune cells by releasing T cell cytokines . These cells help, suppress or regulate immune responses.

• Examples: The cell or tissue damage done during diseases like tuberculosis, leprosy, smallpox, measles, herpes infections, candidiasis, and histoplasmosis the skin test reactions seen for tuberculosis and other infections.

contact dermatitis like poison ivy.

type-1 insulin-dependent diabetes where CTLs destroy insulin-producing cells.

- multiple sclerosis, where T-lymphocytes and macrophages secrete cytokines that destroy the myelin sheath that insulates the nerve fibers of neurons.

- Crohn ’s disease and ulcerative colitis.

- psoriasis.

antibody antigen response time IgE exogenous Table 5 - Comparison of Different Types of hypersensitivity type-II (cytotoxic) IgG, IgM cell surface type-III (immune complex) IgG, IgM soluble 15-30 minutes minutes-hours 3-8 hours type-IV (delayed type) None tissues & organs 48-72 hours appearance weal & flare lysis and necrosis erythema and edema, necrosis erythema and induration histology basophils and eosinophil antibody and complement transferred with antibody antibody complement and neutrophils monocytes and lymphocytes antibody T-cells

Allergic Contact Dermatitis Response to Poison Ivy Hapten

Autoimmune Diseases

A. Type II (Cytotoxic) Autoimmune Reactions Involve antibody reactions to cell surface molecules, without cytotoxic destruction of cells.

Grave’s Disease :

Antibodies attach to receptors on thyroid gland and stimulate production of thyroid hormone.

Symptoms: Goiter (enlarged thyroid) and bulging eyes.

Myasthenia gravis :

Progressive muscle weakness. Antibodies block acetylcholine receptors at neuromuscular synapse.

Affects 25,000 Americans (mainly women).

Today most patients survive when treated with drugs or immunosuppressants.

SLE

Systemic lupus erythematosus, often abbreviated as SLE or lupus, is a systemic autoimmune disease (or autoimmune connective tissue disease the ) that can affect any part of the body. As occurs in other autoimmune diseases, immune system attacks the body's cells and tissue, resulting in inflammation and tissue damage. It is a type III hypersensitivity reaction in which bound antibody-antigen pairs ( immune complexes ) precipitate and cause a further immune response.

SLE

 The disease occurs nine times more often in women than in men, especially in women in child-bearing years ages 15 to 35.

LUPUS (SLE)

the patient’s own DNA, HISTONES, NON histone RNA, and NUCLEOLUS

Pathogenesis: Progressive DEPOSITION and INFLAMMATION to immune deposits, in skin, joints, kidneys, vessels, heart, CNS, LIVER.

Morphology: “Butterfly” rash (NOT discoid)

, skin deposits, glomerolunephritis

Clinical expression: Progressive renal and vascular disease, POSITIVE A.N.A.

INSULIN-DEPENDENT DIABETES MELLITUS (IDDM)  Synonym • Type I diabetes, DM-type I  Accounts for 5% to 10% of diabetes in US  Female to male ratio of 1:1  Effector mechanisms • CD8 T cells and autoantibodies against beta cells • • Glutamic acid decarboxylase (GAD) Insulin

PATHOPHYSIOLOGY OF IDDM

 Pancreatic beta cells are damaged by • • Infectious agents • Mumps virus, rubella virus, coxsackie B virus Toxic chemicals  Damaged beta cells present antigens which trigger immune attack in genetically susceptible

INSULIN-DEPENDENT DIABETES MELLITUS (IDDM)  Symptoms • • • • • Increased thirst Frequent urination Increased hunger Weight loss Fatigue

RHEUMATOID ARTHRITIS (RA)

 Characterized by inflammation of synovial membrane of joints and articular surfaces of cartilage and bone  Involved joints are swollen, warm, painful, and stiff on arising or following inactivity.

 Vasculitis is a systemic complication  Affects 3% to 5% of U.S. population  Female to male ratio of 3:1  HLA DR4 is genetic risk factor

↑ Destructive Rheumatoid Synovitis

NORMAL Bi-Layered Synovium

MULTIPLE SCLEROSIS (MS)  Chronic unpredictable disease of CNS with four possible clinical courses  Characterized by patches of demyelination and inflammation of myelin sheath  Prevalence higher in Northern Hemisphere • • North of 37th parallel (125 cases /100,000) South of 37th parallel (70 cases /100,000)  Female to male ratio of 2:1

MULTIPLE SCLEROSIS (MS)  Effector mechanisms • Myelin basic protein is primary autoantigen for CD4 TH1 cells  Radiology diagnosis • MRI for detecting demyelinating lesions (plaques)

Immunodefeciency disorders

       Defect in B- cell, T- cell, complement or phagocytic cells.

Risk factors A. prematurity B. autoimmune diseases C. lymphoproliferative disorders D. infections E. immunosuppressive drugs

I

mmuno

D

efiency

S

yndromes (-IDS)

PRIMARY (GENETIC) (P IDS)

SECONDARY (

A

CQUIRED) (A-IDS)

          

PRIMARY

CHILDREN with repeated, often severe infections, cellular AND/OR humoral immunity problems, autoimmune defects B-cell disorders BRUTON (X-linked agammaglobulinemia) COMMON VARIABLE IgA deficiency T cell disorders DI GEORGE (THYMIC HYPOPLASIA) 22q11.2

Combined B and T cell disorders SCID (Severe Combined Immuno Deficiency) Wiskott Aldrich syndrome Ataxia telangiectasia

  

(

A)IDS

(SECONDARY IDS)

Etiology: HIV Pathogenesis: Infection, Latency, Progressive T-Cell loss Morphology: MANY  Clinical Expressions: Infections, Neoplasms, Progressive Immune Failure, Death, HIV+, HIV-RNA (Viral Load)

• AIDS Immunodeficiency diseases – – Acquired Acquired after birth, like HIV.

– – HIV targets helper T cells Most patients with AIDS die of opportunisitic infections.

Opportunistic infection:

An infection that occurs because of a weakened immune system . Opportunistic infections are a particular danger for people with system can. AIDS death, but the . The HIV virus itself does not cause opportunistic infections that occur because of its effect on the immune